Athersys to Host First Quarter Financial Results Call

CLEVELAND, April 12, 2018 (GLOBE NEWSWIRE) — Athersys, Inc. (Nasdaq:) will release its first quarter 2018 financial results at approximately 4:00 PM Eastern Time on Thursday, May 10, 2018, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results. Gil Van Bokkelen, Chairman and Chief Executive Officer, and William (B.J.) Lehmann, President and Chief Operating Officer, will host the call as follows:

  DateMay 10, 2018Time4:30 p.m. (Eastern Time)Telephone access: US and CanadaTelephone access: InternationalAccess code1189915Live webcast under Investors section  

A replay will be available for on-demand listening shortly after the completion of the call until 11:59 PM Eastern Time on May 24, 2018 at the aforementioned URL, or by dialing or in the U.S. and Canada, or from abroad , and entering access code 1189915.

About Athersys

Athersys is an international biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a patented, adult-derived “off-the-shelf” stem cell product, initially for disease indications in the neurological, cardiovascular, and inflammatory and immune disease areas, and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance the MultiStem cell therapy toward commercialization.  More information is available at .

ATHX-G

:

William (B.J.) Lehmann, J.D.                              
President and Chief Operating Officer                               
Tel:                                             
 

Karen Hunady
Corporate Communications and Investor Relations
Tel:

David Schull         
Russo Partners, LLC
Tel: or

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.